obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 60 patients 18-55 years old, female, undergoing surgery for gastric bypass with surgery in Roux-Y for more than 24 months and who had regained weight of at least 5% of the lowest weight achieved during treatment.
Exclusion criteria
Exclusion criteria: Patients with decompensated diabetes on hormone treatment, with renal or hepatic disease or using any medication for loss weight.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Weight loss and preservation of lean body mass and greater GER in patients with protein supplementation than in the control patients verified by measurement of weight with calibrated electronic scale considering statistically significant reduction (p <0.05) the parameters mentioned in relation to the values ??found before intervention;Outcome found: significant gain lean mass and weight to the intervention group | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcomes: Statistically significant improvement (p<0:05) in serum adiponectin, cholecystokinin, IL-6, TNF-alpha and insulin in patients who underwent protein supplementation compared with baseline values before the intervention Statistically significant improvement (p<0.05), the resting energy expenditure, body composition and biochemical profile in patients undergoing protein supplementation compared with baseline values before the intervention;Outcome found: No change in the levels of adiponectin, cholecystokinin, IL-6, TNF-alpha and insulin Improvement in glycated hemoglobin levels in both groups and improves total cholesterol and fractions in the control group Significant increase in lean body mass in the intervention group | — |
Countries
Brazil
Contacts
Universidade de Brasília;Universidade de Brasília